genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Pacific Biosciences
GEN Edge
JPM: Illumina’s New CEO Spells Out 2024 Priorities, Presents Preliminary Q4, 2023 Results
Cancer
Zafrens Plans to Advance Multimodal Drug Discovery Platform with $23M Financing
GEN Edge
StockWatch: Investors, Analysts Debate Background of New Illumina CEO
GEN Edge
StockWatch: Despite 3-Week Decline, PacBio Stock Doubles in a Year
Drug Discovery
Charms to Soothe the Savage Microbiome
News
Illumina Shareholders Elect Ally of Icahn to Board, Ousting Chairman
News
StockWatch: Icahn Pursues Illumina Board Seats, and a Sell-Off of Grail
News
Legume’s Giant Genome Sequenced for First Time
News
Verkko Software Assembles T2T Genomes Without the Labwork
Industry News
The Sun Sets on AGBT: A Report from the Last Day
1
2
3
Page 1 of 3
Scroll Up